We are monitoring the impact of COVID-19 on Peptic Ulcer Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date September, 2021
ID: 12181
Share on
Share on

Global Peptic Ulcer Drugs Market Size, Share, Trends, COVID-19 impact & Growth Analysis Report – Segmented By drugs type, ulcer, and region – Industry Forecast (2021 to 2026)

Pulished: September, 2021
ID: 12181
Pages: 200

Global Peptic Ulcer Drugs Market Size (2021 to 2026)

The global peptic ulcer drugs market was valued at around USD 4.80 billion in 2021 and is expected to grow at a compound annual growth rate of 2.64% from 2021 to 2026 and worth USD 5.47 billion by 2026.

A peptic ulcer is a breakage in the inner surface of the stomach or the upper part of the intestine in the gastrointestinal tract. Ulcers form when the protective wall of the intestine or stomach is broken. When the lining is interrupted the acidic gastric juices that contain hydrochloric acid and an enzyme called pepsin irritates the stomach and cause inflammation around it leading to ulcers.

Peptic ulcers represent a group of ulcerative disorders such as gastritis, gastric ulcers, and duodenal ulcers, or gastroesophageal reflux disease (GERD). Treatment of peptic ulcers is carried out with drugs such as proton pump inhibitors (PPIs), competitive potassium acid inhibitors, antacids, H2 antagonists, antibiotics, and ulcer protective drugs such as sucralfate.

MARKET DRIVERS:

The peptic ulcer drugs market is expected to grow at a rapid rate during the forecast period. Lifestyle factors such as increased consumption of soft drinks, alcoholism, fatty foods, and stress can cause peptic ulcers, which is expected to accelerate the growth of the global peptic ulcer drugs market. Peptic ulcers can cause disturbance in lifestyle for older people due to loss of appetite, chronic fatigue, and lethargy. Hence, the increase in this population is a key factor that is expected to drive the market during the forecast period.

Additionally, the increase in chronic diseases and increase in consumption of drugs such as aspirin, ibuprofen, and other inflammatory drugs are the other factors that are predicted to increase the peptic ulcers drugs market. According to the American Cancer Society, In U.S, 32,500 people had stomach cancer in 2018, these numbers rose to 35,500 cases in 2020, while nearly 11,500 people are estimated to die due to complications. According to a 2021 recent study conducted at Harvard University, more than 8 million people suffer from peptic ulcers each year. The increasing number of cases of people suffering from gastrointestinal ulcers is driving the demand for peptic ulcer drugs across the world. In addition, the growing healthcare awareness and availability of peptic ulcer drugs are expected to contribute to the market growth in the coming years.

Growing demand for the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, paracetamol, and others and growing awareness about peptic ulcers and their treatment options are factors expected to trigger the growth of the peptic ulcer drugs market.

MARKET RESTRAINTS:

However, the side effects of long-term use of PPIs, changes in government policies, the loss of market exclusivity for most peptic ulcer drugs, and the limited R&D efforts in the field of peptic ulcer drugs are factors that will hamper the growth of peptic ulcer drugs market across the world.

MARKET OPPORTUNITIES:

A major development for the peptic ulcer drugs market is the increasing preference of patients to opt for drugs to cure their peptic ulcer rather than undergoing surgery. In addition, the increasing attention to research and development activities to find new therapies, sponsored primarily by changing healthcare policies and governments, is also playing an important role in the growth of the peptic ulcer drugs market.

MARKET CHALLENGES:

The reimbursement of medical costs related to certain tests and medicines in some countries, especially in APAC regions, is challenging the growth of the peptic ulcer drugs market.

COVID-19 Impact on the global peptic ulcer drugs market:

The COVID-19 pandemic has crippled a number of industrial processes, causing unprecedented economic losses. In the coming quarters of 2020 and 2021, these combined difficulties in transmitting and treating infections are expected to delay the diagnosis and cure of gastrointestinal illnesses. Decreasing doctor and hospital visits due to the prioritization of COVID-19 care for non-essential health conditions would limit market development. Due to the availability of COVID-19 vaccines, the peptic ulcer drug market is expected to rebound towards pre-pandemic market demands. Pharmaceutical companies are thriving in these difficult times due to the increasing demand for drugs around the world. Likewise, the demand for these ulcer drugs is growing tremendously as large pharmaceutical companies focus more on R&D activities to develop new drugs and meet the demand for over-the-counter drugs in various stores. Hence, the market is expected to show positive growth during the forecast period.

The market is resuming with improved and emerging economies across the world. In addition, local governments are organizing health services to deal with complications from COVID-19.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By drugs type, ulcer, and region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the global peptic ulcer drugs market has been segmented and sub-segmented based on drugs type, ulcer, and region.

Global Peptic Ulcer Drugs Market - By Drug Type:

  • Proton Pump Inhibitors (PPIs)
  • Anti-Histamines
  • H2 Antagonists
  • Antacids
  • Antibiotics
  • Others

Global Peptic Ulcer Drugs Market -By Ulcer Type:

  • Gastric Ulcers
  • Duodenal Ulcer
  • Esophageal Ulcer

Global Peptic Ulcer Drugs Market -By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Geographically, North America and Europe collectively accounted for 67% of the total revenue share in the global peptic ulcer drugs market in 2020. The U.S. peptic ulcer drug market was estimated at USD 1.4 billion in 2020, while Canada is estimated to grow at a CAGR of 2.55% during the forecast period. North America was worth USD 2.06 billion in 2020 and is expected to hold the largest market share in the coming years. This market growth in the region is due to the increase in incidences of peptic ulcers patients in the United States.

The Asia-Pacific regional market held 23% of the overall peptic ulcer drug market share and this trend is estimated to gain similar growth during the forecast period, owing to the increased case of recurrent peptic ulcers in patients. China will be one of the fastest-growing Asian countries in the APAC regions. Led by countries like Australia, India, and South Korea, the Asia-Pacific market is expected to reach USD 698 million by 2026.

The MEA market is expected to grow at a slow and steady rate during the forecast period, owing to the low accessibility of peptic ulcer drugs and poor healthcare infrastructure in the region. Other regional markets such as Saudi Arabia and UAE, will be growing at a CAGR of 2.8% and 2.1% respectively over the period 2020-2027.

In Europe, Germany is expected to grow at 2.8% CAGR from 2021 to 2026. The growing awareness of peptic ulcers in humans is one of the emerging trends in the European peptic ulcer drugs market in the coming years. The growth of the European market can be attributed to the increasing number of patients suffering from peptic ulcers as well as increasing healthcare spending in European countries such as Germany, the UK, and France. The market demand in Germany is mainly due to the easy availability of medicines and effective treatment options for peptic ulcers.

On the other hand, Latin America is expected to occupy a moderate share in the global market during the forecast period in the global market. This is attributable to factors such as lesser healthcare spending in countries like Peru, Chile, and Ecuador from 2021 to 2026.

KEY MARKET PLAYERS:

Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc., Helicure AB and Eumedica Pharmaceuticals are some of the companies currently dominating the global peptic ulcer drugs market and profiled in this report.

RECENT MARKET DEVELOPMENTS:

  • In October 2019, Novitium Pharma LLC recalled ranitidine hydrochloride capsules in the United States due to elevated levels of NDMA (N-nitrosodimethylamine), a suspected human carcinogen, above FDA limits.
  • In Novermber 2019, to expand their product line, major market players are focusing on product acceptance and launch. Talicia, treatment for Helicobacter pylori infection in adults.
  • The company ‘RedHill Biopharma’ announced the commercial launch in the United States of Talicia, a capsule to treat H. pylori infection in patients in March 2020. The announcement made the company one of the leading pharmaceutical companies in the world.

1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restraints          

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquisition Landscape                       

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1 Global Peptic Ulcer Drugs Market - By Drug Type:                     

                        6.1.1  Proton Pump Inhibitors (PPIs) 

                        6.1.2  Anti-Histamines

                        6.1.3    H2 Antagonists           

                        6.1.4  Antacids

                        6.1.5  Antibiotics        

                        6.1.6 Others   

                        6.1.7 Market Size Estimations & Forecasts (2021-2026)      

                        6.1.8 Y-o-Y Growth Rate Analysis      

                        6.1.9 Market Attractiveness Index    

            6.2 Global Peptic Ulcer Drugs Market -By Ulcer Type:                      

                        6.2.1 Gastric Ulcers    

                        6.2.2 Duodenal Ulcer 

                        6.2.3  Esophageal Ulcer         

                        6.2.4 Market Size Estimations & Forecasts (2021-2026)      

                        6.2.5 Y-o-Y Growth Rate Analysis      

                        6.2.6 Market Attractiveness Index    

7. Geographical Landscape                            

            7.1 Global Identity Governance and Administration Market, by Region                  

            7.2 North America - Market Analysis (2021 - 2026)              

                        7.2.1 By Country        

                                    7.2.1.1 USA

                                    7.2.1.2 Canada

                        7.2.2 By Drug Type:   

                        7.2.3 By Ulcer Type:   

            7.3 Europe                 

                        7.3.1 By Country        

                                    7.3.1.1 UK

                                    7.3.1.2 France

                                    7.3.1.3 Germany

                                    7.3.1.4 Spain

                                    7.3.1.5 Italy

                                    7.3.1.6 Rest of Europe

                        7.3.2 By Drug Type:   

                        7.3.3 By Ulcer Type:   

            7.4 Asia Pacific                       

                        7.4.1 By Country        

                                    7.4.1.1 China

                                    7.4.1.2 India

                                    7.4.1.3 Japan

                                    7.4.1.4 South Korea

                                    7.4.1.5 South East Asia

                                    7.4.1.6 Australia & NZ

                                    7.4.1.7 Rest of Asia-Pacific

                        7.4.2 By Drug Type:   

                        7.4.3 By Ulcer Type:   

            7.5 Latin America                   

                        7.5.1 By Country        

                                    7.5.1.1 Brazil

                                    7.5.1.2 Argentina

                                    7.5.1.3 Mexico

                                    7.5.1.4 Rest of Latin America

                        7.5.2 By Drug Type:   

                        7.5.3 By Ulcer Type:   

            7.6 Middle East and Africa                 

                        7.6.1 By Country        

                                    7.6.1.1 Middle East

                                    7.6.1.2 Africa

                        7.6.2 By Drug Type:   

                        7.6.3 By Ulcer Type:   

8. Key Player Analysis                        

            8.1 Novartis AG                      

                        8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

                        8.1.6 Analyst Overview          

            8.2 Daiichi Sankyo Company Limited            

            8.3 Acetelion Ltd                    

            8.4 Boehringer Ingelheim                  

            8.5 Sanofi S.A.            

            8.6 Astra Zeneca                    

            8.7 Ranbaxy Laboratories Limited, Inc.                     

            8.8 Takeda Pharmaceuticals Company Limited                    

            8.9 Pfizer Inc.             

            8.10 Helicure AB                    

            8.11 Eumedica Pharmaceuticals                    

9. Market Outlook & Investment Opportunities                               

10. Appendix                          

            List of Tables              

            List of Figures             

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 

  • The segment-level analysis in terms of drugs type, ulcer type, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

  1. Global peptic ulcer drugs market By Region, From 2021 to 2026 ( USD Billion )

  2. Global peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  3. Global  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  4. Global Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  5. Global H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  6. Global   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  7. Global Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  8. Global Others Market By Region, From 2021 to 2026 ( USD Billion )

  9. Global peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  10. Global   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  11. Global Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  12. Global Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  13. North America peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  14. North America  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  15. North America Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  16. North America H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  17. North America   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  18. North America Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  19. North America Others Market By Region, From 2021 to 2026 ( USD Billion )

  20. North America peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  21. North America   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  22. North America Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  23. North America Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  24. United States peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  25. United States peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  26. Canada peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  27. Canada peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  28. Europe peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  29. Europe  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  30. Europe Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  31. Europe H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  32. Europe   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  33. Europe Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  34. Europe Others Market By Region, From 2021 to 2026 ( USD Billion )

  35. Europe peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  36. Europe   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  37. Europe Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  38. Europe Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  39. U.K. peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  40. U.K. peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  41. Germany peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  42. Germany peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  43. France peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  44. France peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  45. Italy peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  46. Italy peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  47. Spain peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  48. Spain peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  49. Asia Pacific peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  50. Asia Pacific  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  51. Asia Pacific Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  52. Asia Pacific H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  53. Asia Pacific   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  54. Asia Pacific Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  55. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Billion )

  56. Asia Pacific peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  57. Asia Pacific   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  58. Asia Pacific Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  59. Asia Pacific Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  60. Japan peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  61. Japan peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  62. China peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  63. China peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  64. India peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  65. India peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  66. Australia peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  67. Australia peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  68. South Korea peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  69. South Korea peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  70. Latin America peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  71. Latin America  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  72. Latin America Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  73. Latin America H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  74. Latin America   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  75. Latin America Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  76. Latin America Others Market By Region, From 2021 to 2026 ( USD Billion )

  77. Latin America peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  78. Latin America   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  79. Latin America Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  80. Latin America Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  81. Brazil peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  82. Brazil peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  83. Argentina peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  84. Argentina peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  85. Mexico peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  86. Mexico peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  87. Rest of Latin America peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  88. Rest of Latin America peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  89. Middle East and Africa peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  90. Middle East and Africa  Proton Pump Inhibitors (PPIs) Market By Region, From 2021 to 2026 ( USD Billion )

  91. Middle East and Africa Anti-Histamines Market By Region, From 2021 to 2026 ( USD Billion )

  92. Middle East and Africa H2 Antagonists Market By Region, From 2021 to 2026 ( USD Billion )

  93. Middle East and Africa   Antacids Market By Region, From 2021 to 2026 ( USD Billion )

  94. Middle East and Africa Antibiotics Market By Region, From 2021 to 2026 ( USD Billion )

  95. Middle East and Africa Others Market By Region, From 2021 to 2026 ( USD Billion )

  96. Middle East and Africa peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  97. Middle East and Africa   Gastric Ulcers Market By Region, From 2021 to 2026 ( USD Billion )

  98. Middle East and Africa Duodenal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  99. Middle East and Africa Esophageal Ulcer Market By Region, From 2021 to 2026 ( USD Billion )

  100. Middle East peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  101. Middle East peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

  102. Africa peptic ulcer drugs market By Drug Type, From 2021 to 2026 ( USD Billion )

  103. Africa peptic ulcer drugs market By Ulcer Type, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4250

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample